More data suggests reduced risks of hospitalization and death due to SARS-CoV-2 Omicron compared to the Delta variant.

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study – The Lancet

Invited Commentary: Omicron: fewer adverse outcomes come with new dangers – The Lancet

Commentary on Twitter

NEW—People with SARS-CoV-2 #omicron variant less likely to be admitted to hospital or die compared to those with delta variant, indicates large English study. https://t.co/xZvH5qMRDJ pic.twitter.com/fnn7xMBYDB

— The Lancet (@TheLancet) March 17, 2022